Return On Equity of ZyVersa Therapeutics, Inc. from 12 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ZyVersa Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 12 Dec 2022 to 30 Sep 2025.
  • ZyVersa Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -933%, a 315% decline year-over-year.
  • ZyVersa Therapeutics, Inc. annual Return On Equity for 2024 was -106%, a 60% increase from 2023.
  • ZyVersa Therapeutics, Inc. annual Return On Equity for 2023 was -266%, a 322% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ZyVersa Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -933% -708% -315% 01 Jul 2025 30 Sep 2025
Q2 2025 -111% +61% +35% 01 Apr 2025 30 Jun 2025
Q1 2025 -110% +519% +83% 01 Jan 2025 31 Mar 2025
Q4 2024 -106% +159% +60% 01 Oct 2024 31 Dec 2024
Q3 2024 -225% -81% -56% 01 Jul 2024 30 Sep 2024
Q2 2024 -173% -17% -11% 01 Apr 2024 30 Jun 2024
Q1 2024 -629% -619% -6242% 01 Jan 2024 31 Mar 2024
Q4 2023 -266% -264% -12587% 01 Oct 2023 31 Dec 2023
Q3 2023 -144% 01 Jul 2023 30 Sep 2023
Q2 2023 -156% 01 Apr 2023 30 Jun 2023
Q1 2023 -10% 01 Jan 2023 31 Mar 2023
Q4 2022 -2% 13 Dec 2022 31 Dec 2022

ZyVersa Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -106% +159% +60% 01 Jan 2024 31 Dec 2024
2023 -266% -203% -322% 01 Jan 2023 31 Dec 2023
2022 -63% 01 Jan 2022 12 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.